Drug Approval | November 22, 2021
European Commission approves Roche’s Gavreto
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Achondroplasia is a genetic condition that causes severely short stature and disproportionate growth
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
This test is inexpensive and results are available immediately as compared to the genetic test
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
The centre has an initial capacity of 500 FTEs
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Subscribe To Our Newsletter & Stay Updated
